When there is bad news to report, it is tempting to have it out on the person who reports it. Your car costs a bomb to repair; you are annoyed with your mechanic. A parcel has been lost; you get angry with your postman. Your account is overdrawn; you get stroppy with the bank manager. We all know this behavior is silly, but, after all, we are only human.
Researching complementary and alternative medicine (CAM) for the past 13 years, I have been the bearer of "bad" news on a fairly regular basis. A few examples may suffice. In 1999, we published the first ever randomized clinical trial (RCT) of (Bach) flower remedies (Armstrong & Ernst, 1999) . Its results failed to show effectiveness beyond a placebo response. This caused an outcry among Bach enthusiasts. Meanwhile, about half a dozen RCTs have become available, and none demonstrates effects beyond placebo. From the beginning of my journey into CAM research, I insisted that safety is too important an issue to be left to conjecture and insisted that data were required to be sure (Ernst, 1993) . By and large, CAM enthusiasts disagreed emphatically. When, 10 years ago, our survey data suggested that many patients experience adverse effects after CAM (Abbot, White, & Ernst, 1996) , our critics did not mince their words. Today, we know that many forms of CAM raise important safety issues (Ernst, 2000) , and we are beginning to address them (House of Lords Select Committee on Science and Technology, 2000) . When our RCT demonstrated that spiritual healing had no specific therapeutic effects (Abbot et al., 2001) , healers were angry. Meanwhile, this finding has been replicated many times in larger and more robust studies.
Throughout the past 13 years, our work has been criticized. Luckily, I enjoy constructive criticism; it can be helpful and advance things. However, I do not relish personal attacks: They are destructive. In recent months, I have noted a distinct increase of the latter category of criticism. Again, a few examples (presented below as quotes) may suffice:
• "Significant flaws . . . cast an extremely negative light on both authors" (Breen, Vogel, Pincus, Foster, & Underwood, 2006) . • "His letter demonstrates a naivety that ill becomes a professor" (Woodward, 2006) . • He [Professor Ernst] "should receive no support for his research from those involved in complementary healthcare" (Woodward, 2006) . • "He is always attempting to undermine that which he is employed to promote" (Needleman, 2006) . • He has "an obsequious manner" (Goodman, 2006 ).
• He "argues the case for pharmaceutical medicine" (Walker, 2006) . • His comments are "irresponsible and a danger to public health" ("Ernst Claims," 2006) .
• "Honour demands that, as a matter of urgency" Professor Ernst "now seriously consider
[his] position" (Milgrom, in press ).
As I mentioned above, "shooting the messenger" may be a human reaction, but we all know it is silly. When it happens regularly, it signals, I believe, immaturity. My interpretation of personal attacks related to "negative" results generated by CAM research therefore is that CAM has a long way to go until it becomes a mature field.
What is a "negative" result anyway? If flower remedies or spiritual healing or any other treatment is shown to be ineffective or if risks of CAM are disclosed, for whom can this be negative? Clinical research is about patients, and for patients, such findings can only be positive: They can subsequently opt for truly effective treatments or avoid risks. It follows, I think, that the terminology of negative points to a much deeper problem. Those who think in terms of negative results may not be as interested in patients' welfare as they pretend to be.
I have always found the notion of dividing the world of CAM into proponents or opponents most extraordinary and ridiculous. This polarization does not help anyone and, in the past, has created much more heat than light. What is needed, I am convinced, is solid evidence that adheres to the standards applied currently in the rest of medicine. We have recently published the update of our Desktop Guide to Complementary and Alternative Medicine (Ernst, Pittler, Wider, & Boddy, 2006) . In this book, we transparently (explaining our methodology in a dedicated chapter) evaluate the evidence as it relates to 69 common CAM interventions. In addition, we summarize the evidence for or against CAM therapy of 46 common conditions. Table 1 lists those conditions for which various CAM modalities are now solidly backed up by evidence from controlled trials. I think this list, which has more than doubled in length during the past 5 years, is impressive. Note. This list is based on a review of the existing evidence. Only condition/intervention combinations are listed for which the amount, quality, and quantity of evidence were sufficient and the direction of the evidence was clearly in favor of the intervention. Data were extracted from Ernst, Pittler, Wider, and Boddy (2006) .
My conclusion is simple: Without hard evidence of a standard that convinces even the skeptics, CAM will have no future in the long-term, and shooting the messenger will not change that either.
